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Introduction
Aneurysmal subarachnoid hemorrhage (SAH) is associated with high morbidity and mortality, with death rates ranging from 25% in contemporary observational series [1] to close to 10% in randomized trials [2, 3] . Roughly 30% of survivors suffer from severe permanent disability [4] , and significant cognitive and psychosocial impairment is present in a large amount of patients [5] [6] [7] . In patients with aneurysmal SAH, ischemic lesion burden is a known predictor of worse outcome [8, 9] . Currently, there is no single clinical method or ancillary test that can reliably predict which subset of patients will develop delayed cerebral ischemia (DCI). The ability to stratify patients into high-and low-risk categories at the onset of hemorrhage would be useful in guiding early aggressive care. Transcranial Doppler (TCD) ultrasonography has been used for decades as a tool for screening patients at risk for developing cerebral vasospasm, but the method lacks sensitivity and suffers from high interobserver variability [10, 11] . Fisher and modified Fisher grades are based on the amount of subarachnoid blood on computed tomographic (CT) brain scan on admission and can fairly predict development of DCI, but with lower positive predictive values in patients with small amounts of blood [12] [13] [14] [15] . Previous animal and human studies suggest that SAH leads to a state of systemic inflammation, with DCI as the most striking manifestation [16] [17] [18] [19] . At the same time, anemia has been associated to worse outcomes and the occurrence of DCI [20] [21] [22] [23] . Leukocytosis and anemia could represent early markers of bone marrow changes due to systemic inflammation, and serve as early surrogate markers for such a state. The aim of this study was to find hematologic derangements and clinical factors present during the first 7 days after bleeding that could help identify patients at risk for development of DCI.
Methods

Study population
A databank of aneurysmal SAH was created using patients admitted from 2010 to 2012, in a large quaternary academic center in Cleveland, Ohio. Fifty-five patients with aneurysmal SAH admitted through this period were included in our study. The entry criteria consisted of any patients with confirmed aneurysmal SAH on cerebral angiogram, who stayed at least 7 days in the hospital (counted from the day of bleeding), and with information available for all the study variables. We chose to analyze the first 7 days after bleeding, as this is the peak period for occurrence of vasospasm in most patients with SAH. Characteristics of participant patients are presented in Table 1 .
Variables of interest
Data from demographics (age, sex), imaging (TCD ultrasound, CT, and cerebral angiogram, including size and location of the aneurysm), laboratory (white blood cell [WBC] count, hemoglobin concentration and serum sodium daily for the first 7 days, cardiac dysfunction on echocardiography), and clinical factors (fever, occurrence of DCI and radiographic vasospasm, Hunt-Hess and modified Fisher scales on admission, surgical correction of the aneurysm) were collected.
We chose to analyze WBC count and hemoglobin concentration on day 3 after bleeding, as this is usually when vasospasm ensues in most patients [24, 25] . We defined anemia as a hemoglobin concentration less than 10 mg/dL, as this was found to be probably correlated with infarcts secondary to vasospasm and mortality in previous studies [21, 22] . Moreover, positron emission tomography studies in SAH patients indicate that raising hemoglobin concentration with red blood cell transfusion from 8 to 10 g/dL improves cerebral oxygen delivery [26] , and expert opinion per formal guidelines suggests that levels 8-10 mg/dL should be maintained in patients with SAH, depending on the risk of DCI [24] . Leukocytosis is harder to define, as in theory it should be the total WBC count more than 2 SDs above the mean in a normally distributed population; most laboratories have values ranging from 10 000 to 11 000 leukocytes per mm 3 as the upper limit for a WBC count [27] . We defined our cutoff as 10 000 leukocytes per mm 3 after a receiver operating curve was done using the data from our study, correlating WBC with DCI, and it was found an area under the curve of 0.68, with values ranging from 10.01 to 10.46 × 1000 leukocytes per mm 3 to be suggested as with higher sensitivity/specificity. Youden index calculation of the best cutoff using the receiver operating characteristic curve values identified 10.03 as the most accurate value. For statistical purposes, Hunt-Hess scale was dichotomized in 1-2 and N2 (good neurologic grade vs disfavorable grade) and modified Fisher scale was dichotomized in 1-2 and 3-4 (lower risk of vasospasm vs higher risk).
Outcome measures
We defined DCI as clinical deterioration deemed secondary to vasospasm (confirmed with digital subtraction angiography) after other causes were eliminated [8] (such as fever, infection, hyponatremia, seizures, hydrocephalus) and radiographic vasospasm as arterial narrowing diagnosed on digital subtraction angiography [24] . Moderate narrowing was defined as at least 50% decrease in vessel lumen. In comatose patients, DCI was defined as new infarcts on brain CT or magnetic resonance scans with radiographic vasospasm on digital subtraction angiography, and not deemed to be secondary to endovascular procedures [24] .
Statistical analysis
First, the chosen metabolic/clinical/radiologic variables were independently tested to check association to the outcome variable (DCI) using Pearson χ 2 and Fisher exact test for categorical variables, t test for normally distributed continuous variables, and Mann-Whitney U test for nonparametric continuous variables, as well as univariate logistic regression analysis. Afterward, the variables with statistical significance (cutoff of P b .05) were added to a multivariate logistic regression model to assess whether the statistical significance persisted after correction for predefined important demographic and clinical variables (Hunt-Hess, modified Fisher Scale, age, and sex). Finally, a stepforward logistic regression modeling was performed to assess the best predictive model. All variables were independent, and no collinearity was detected. In the end, Hosmer-Lemeshow test was performed to assess goodness -of-fit of the final model. Statistical software BioStat (version 5.4; São Paulo, Brazil) was used for all analyses.
Results
Of 55 patients, 14 developed DCI (25%). Anemia and leukocytosis on the third day after bleeding were significantly correlated with the outcome (for anemia: P b .032; confidence interval [CI], 1.12-15.16; odds ratio [OR], 4.12; for leukocytosis: P b .046; CI, 1.03-26.13; OR, 5.18). The occurrence of fever or hyponatremia, age, sex, size and location of the aneurysm, surgical correction of the aneurysm, Hunt-Hess scale or modified Fisher scale on arrival, presence of cardiac dysfunction, and middle cerebral artery mean flow velocities greater than 120 cm/s on TCD sonography were not correlated with the outcome. Table 2 shows the results for all tested variables. A multiple logistic regression was performed to assess the influence of the other nonsignificant variables when analyzed concurrently. Anemia and leukocytosis were still statistically significant after adjustment for age, sex, modified Fisher scale, Figs. 1 and 2 show the hemoglobin and WBC counts graphed per population.
The findings remained the case even when retested including only patients with mean flow velocities of the middle cerebral arteries lower than 120 cm/s on TCD sonography performed on the third day after bleeding. Although our main goal was not to directly compare the diagnostic accuracy of TCD vs inflammatory markers, our data serves as a hypothesis generator that the presence of anemia and leukocytosis was predictive of DCI even among patients deemed of low risk according to TCD criteria.
Discussion
In our study, the presence of hematologic derangements on the third day after SAH was statistically correlated with the occurrence of DCI, even after correction for concurrent risk factors.
Some previous studies have noticed a trend for increased mortality and poor prognosis associated with leukocytosis during hospital stay in patients with aneurysmal SAH, but most analyzed the occurrence of blood count changes in any time frame or even after DCI was established [28] [29] [30] [31] [32] [33] [34] . Also, the presence of leukocytosis was not corrected against other variables in regression models. One study conducted in the United States showed a relationship between peak leukocyte counts (above 15 × 1000/mm 3 ) and development of DCI, but it analyzed the presence of peaks above this cutoff occurring in any days between 0 and 5 after bleeding [35] . Moreover, it used a very high cutoff in a series where DCI developed in 45% of the patients, higher than our cohort and most previous studies [24, [36] [37] [38] .
A growing number of animal and human studies suggest that SAH leads to a state of systemic inflammation, with vasospasm as the most striking manifestation [16] [17] [18] [19] . Leukocytosis and anemia could be early markers of bone marrow changes due to systemic inflammation, and serve as early surrogate markers for this state. A cohort study in Sweden has shown that high leukocyte count at baseline was associated with increased incidence of SAH, mainly in smokers [18] . The third day after the initial hemorrhage is suggested to host the initial peak of inflammation in human and animal studies. Cerebral spinal fluid neutrophilia on the third day in patients with SAH was an independent predictor of the later development of DCI in a previous study [39] , and depletion of neutrophils 3 days after SAH in a murine model mitigated tissue inflammation, reversed cerebral vasoconstriction, and restored memory mechanisms at day 6 [40] . Finally, none of the patients from our cohort developed infections during the 7-day period of observation, minimizing the possibility of observing leukocytosis secondary to bacterial infections.
Anemia has been associated with the occurrence of DCI and worse prognosis in previous studies [21, 41, 42] , as well as leading to metabolic distress detected by cerebral microdialysis [20, 23, 43] . Conversely, studies assessing the impact of blood transfusions in this population have led to conflicting results, not necessarily improving outcomes [26, [44] [45] [46] . In critically ill patients, anemia is frequently observed and is hypothesized to occur as a consequence of systemic inflammation leading to myelosuppression, blunted erythropoietin production and erythropoietin response, and abnormalities in iron metabolism [47] [48] [49] . It is quite common to detect anemia during the acute phase of SAH [21, 50, 51] , even as early as the third to fifth days after bleeding, before the effect of blood loss secondary to multiple blood draws is noticed, suggesting a possible involvement of systemic inflammation.
A point of discussion is that our study showed a statistical correlation, but causal inferences are harder to assert. For example, patients with infections or more frequent blood draws are likely sicker and might be at higher risk for developing DCI. However, in the present study, blood samples were collected daily from all patients. In addition, none of the patients received blood transfusions before day 3, and none were anemic on arrival. Subarachnoid hemorrhage is a condition where early diagnosis and aggressive therapy are some of the pillars of therapy, but until today, very few data are available on predicting which subset of patients are at higher risk for complications. The modified Fisher and the Hunt-Hess scales are traditionally considered predictors of DCI, but were surprisingly not associated with the outcome in the current study. It might be related to its small sample size, but also to the fact that high scores in both scales could be closely related to the occurrence of early brain injury soon after aneurysm rupture [52, 53] , impacting long-term functional outcomes even before DCI ensues. Finally, hemoglobin concentration can be influenced by volemic status. A strategy of euvolemia for prevention of DCI is adopted in our neurocritical care unit, with the use of daily weight and bedside ultrasonography (inferior vena cava and lung parenchyma analysis).
Although the current study was retrospective and the cohort relatively small in number, it did disclose a trend for prediction of DCI. To our knowledge, it is the first in the literature to analyze in a very comprehensive way using multiple clinical, radiologic, and laboratorial variables the early phase of SAH, in regard of prediction of DCI occurrence. Studies on SAH are not easily performed, as the disease is not as common as other forms of acute brain disease; also, studies analyzing the early phase soon after arrival of patients with SAH are scarce. We hope that our study could become a hypotheses generator for future investigation.
Conclusion
The presence of leukocytosis and anemia during the third day after SAH was statistically correlated with the occurrence of DCI. Further investigation is needed to assess the broader applicability of these findings.
